Congress moves to block Medicare's prior-authorization cost-control rule

What it does

This resolution disapproves a Medicare rule (WISeR Model) that requires prior authorization for certain medical services, blocking it from taking effect. The rule was designed to reduce wasteful or inappropriate services in Medicare. If passed, the resolution would nullify the rule entirely, allowing Medicare to proceed without this prior-authorization requirement.

Why we flagged it

This is a standard CRA disapproval resolution under 5 U.S.C. chapter 8, which allows Congress to nullify agency rules within a defined window. It names a specific rule and votes to block it; the mechanism is procedural and transparent.

What the text implies

• Disapproving the rule does not prevent CMS from resubmitting a similar prior-authorization rule in the future, potentially with minor modifications to avoid the same disapproval.
• Prior authorization delays can harm patients by postponing necessary care; blocking the rule may increase access speed but also increase inappropriate or duplicative services, raising Medicare spending.
• The rule's disapproval may shift cost-control burden to other mechanisms (e.g., payment rates, utilization review), potentially affecting provider reimbursement differently.
• If the WISeR Model was piloting a targeted prior-authorization approach, disapproval eliminates data on its effectiveness, making future evidence-based policy harder.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Blocking prior authorization removes administrative friction for patients and providers, reducing delays in care access. However, prior authorization is also a cost-control mechanism; eliminating it may increase unnecessary or wasteful services, raising Medicare costs and potentially benefiting providers over taxpayers. The net effect depends on whether the WISeR rule's prior-authorization criteria were well-designed or overly restrictive.

Who stands to gain

• healthcare providers (reduced prior-authorization administrative burden)
• medical device and pharmaceutical suppliers (fewer authorization denials)

Named in the bill

Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services (HHS), Medicare, WISeR Model (Wasteful and Inappropriate Services Reduction), Government Accountability Office (GAO), Congress

Where it stands

9 cosponsors: 9 Democrats.

• May 19, 2026 — Introduced · Congress.gov: “Introduced in House”
• May 19, 2026 — Referred to House Committee on Energy and Commerce and House Committee on Ways and Means · Congress.gov: “Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $142,230 in lobbying spend. A filing names 20 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

Greg Landsman, the sponsor, reported $1,006,728 in PAC receipts in the 2026 cycle.

• National Association of Accountable Care Organizations — $142,230 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.